Hosted on MSN6mon
Research explores genetic treatment for rare arrhythmiasAntisense oligonucleotides (ASO) are an emerging pharmaceutical option ... Variants in any one of those genes affect the binding and signaling processes, causing calmodulinopathy.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback